Navigation Links
Outsmarting the smartie bug

New tools in the fight against pneumococci ?the bugs targeted by vaccines recently announced by the Department of Health ?are described by a team led by scientists from the Wellcome Trust Sanger Institute. They have put together a complete description of the targets of the vaccine that will help monitor the disease and provide new tools for rapid diagnosis.

Pneumococci (formal name Streptococcus pneumoniae) are widespread, causing non-invasive disease, such as ear and sinus infections, and rarer, invasive disease, such as pneumonia and meningitis. About one in three children each year has an ear infection, of which about one-third will be due to the pneumococcus. More significantly, invasive disease is a major cause of death: around 1 million people, mostly young children in developing countries, die each year.

The research, published online today in PLoS Genetics, shows how the target of the vaccines, called the polysaccharide capsule, has evolved and allows the researchers to determine functions of the genes involved. The polysaccharide capsule forms a sugary coat around the bacterium and changing the structure of the capsule can help it to fool our immune defence systems ?like a Smartie changing its colour.

"The bug has a polysaccharide coat which can take any one of 90 different forms, known as serotypes," said Stephen Bentley, leader of the project at the Wellcome Trust Sanger Institute. "The coat is essential for its ability to cause disease and its interaction with our immune system and some serotypes are more likely to be associated with disease."

"The current vaccines provide excellent protection against pneumococcal disease, but only that caused by some of the 90 serotypes, and it is important that we keep a watch on the development of this organism. Our work in describing all known variants will help in that surveillance"

Two vaccines are available. The first, PCV, recognizes seven forms of the capsule and protec
'"/>

Source:Public Library of Science


Page: 1 2 3

Related biology news :

1. New insight into people who see colors in letters and numbers
2. Alaskan puzzles, monitoring provide insight about North Pacific salmon runs
3. New insight into regulation of blood stem cells
4. New insight into autoimmune disease: Bacterial infections promote recognition of self-glycolipids
5. New insights into how Huntingtons disease attacks the brain
6. Gambling monkeys give insight into neural machinery of risk
7. Structures of marine toxins provide insight into their effectiveness as cancer drugs
8. Flies on speed offer insight into the roles of dopamine in sleep and arousal
9. Grasshopper love songs give insight into sensory tuning
10. Studies on human genome variation provide insight into disease
11. Study provides insight into cellular defenses against genetic mutation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Outsmarting the smartie bug

(Date:11/26/2009)...nt Staphylococcus Aureus ) and other drug-resista...ture plasma prototype devices have been developed ...dal cocktails. , Two prototype devices have been...thy skin (e.g. hands and feet) in hospitals and pu...t; and another to shoot bacteria-killing agents in...
(Date:11/25/2009)...ters, police officers and ambulance workers faced ...er complex. They battled to save people from the c...kled fires and evacuated as many people as they co... people. And making their jobs even harder was the...s and their relatives jammed mobile networks with ...
(Date:11/25/2009)... assistant professors recently received funding fr...ue research beneficial to understanding the enviro...opher Blackwood, assistant professor in the Depart... support two separate research projects. , His f... Communities and Functions from the Leaf to the La...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Hologic to Release Third Quarter Fiscal 2009 Operating Results on Monday August 3 2009 51476 1Hologic to Release Third Quarter Fiscal 2009 Operating Results on Monday August 3 2009 51476 2Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 1Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 2Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 3Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 4Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 5Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 6Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 7Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 8Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 9Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Virginia AARP Members 51473 10Integrative Dermatology of Boca Raton Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51468 1Integrative Dermatology of Boca Raton Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51468 2Integrative Dermatology of Boca Raton Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51468 3
...ntists at the University of Liverpool have found h... spread of cancer cells. , Researchers discovered ...eld around cancer cells and prevents them from cau...tein that exists in the blood. , In diseases su... cells lose growth control and eventually form tum...
...n bone marrow has been used to create early-stage ...forward that will help researchers understand more...h published today (Friday, April 13 2007), in the ... carried out in Germany* by a team of scientists l...iversity of Göttingen but now of the North-east En...
...to growers are likely to soon be able to cultivate...ides against grey mould (Botrytis cinerea). This i...chard Finkers from Wageningen University, with whi... Finkers designed highly efficient methods whereby...The leading company De Ruiter Seeds is already app...
Other Biology News:Scientists discover how body fights to control spread of cancer 2Early-stage sperm cells created from human bone marrow 2Research on grey mould offers possible breakthrough in tomato cultivation 2
(Date:11/24/2009)..., , SAN MATEO, Calif., Nov. 24 /PRNewsw..., a biopharmaceutical company focused on developin...ies, announced today that Anthony DiTonno, Preside...esent at the 21st Annual Piper Jaffray Health Care...New York Palace Hotel in New York, New York. ,...
(Date:11/24/2009)..., , , Primary efficacy endpoint has bee...rrent endometrial cancer, , QUEBEC CITY, Nov.... (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a glo... therapy and oncology, today announced positive ef... cytotoxic peptide conjugate, AEZS-108 (formerly A...
(Date:11/24/2009)..., , REDWOOD CITY, Calif., Nov. 24 /PRNews...GHDX ) today announced that Randy Scott, Genomic H...st Annual Piper Jaffray Health Care Conference in ...0 a.m. ET. ,, To access the live and subsequen...e Investor Relations section of Genomic Health,s w...
(Date:11/24/2009)..., , SEATTLE, Nov. 24 /PRNewswire-FirstC...MTA: CTIC) management will present at the 21st Ann...erence will be held December 1-2, 2009, at the New...esday, December 1 at 11:00 a.m. Eastern Time in Ho...presentation will be available at www.celltherape...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...ounced,today that it has been awarded a $12.9 mill...and Infectious Diseases (NIAID), a part of the US,...ense research in the area,of infectious disease bi...r a five-year period, Caprion,will act as one of t...s,Disease & Biodefense, and will employ its distin...
...09 for $5,000 each, MOUNTAIN VIEW, Calif., Oct. 6... genome sequencing company, today announced its,fo...-scale human genome,sequencing services., The com...n operating in,"stealth mode" from a 32,000-square...o and a half years, Complete Genomics has been rei...
...ment resulting from years of, study by leading r..., Del-Immune V, BOUL...at,the EUPROBIO 2008 Conference, an abstract entit...nduction and its impact on cytotoxicity of,natural...searchers and,educators. Attendees to the presenta...
Other Biology Technology:Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract 2Complete Genomics Launches, Becomes World's First Large-Scale Human Genome Sequencing Company 2Complete Genomics Launches, Becomes World's First Large-Scale Human Genome Sequencing Company 3Complete Genomics Launches, Becomes World's First Large-Scale Human Genome Sequencing Company 4EUPROBIO 2008 Presentation to Highlight Latest Immune Research 2
Klenow Enzyme; labeling grade, DNA Polymerase I, large fragment from Roche Applied Science
DNA Polymerase I Large (Klenow) Fragment from New England Biolabs
T4 DNA Ligase (HC) from Invitrogen
Rat Anti-STENOTROPHOMONAS MALTOPHILIA Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: